Opinion: Science in the Courtroom

Should biological explanations for criminal behavior influence a judge’s or jury’s decision about how to handle a case? If so, how?

Written byJames Tabery
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

An original Victorian Courtrooms at the Galleries of Justice Museumin Nottingham, EnglandWikimedia, FayerollinsonScientific evidence concerning the biological causes of bad behavior is becoming increasingly common in the courtroom. Forensic psychiatrists at Vanderbilt University have genetically screened defendants charged with first-degree murder for a gene associated with antisocial personality disorder, for example. And when it came time to sentence convicted murderer Brian Dugan, neuroscientists performed neuroimaging on Dugan's brain in order to claim he has a defective, psychopathic brain.

What would you do if you were faced with such a decision? Imagine you're a juror tasked with the job of recommending a sentence for a criminal found guilty of aggravated battery. The criminal, Jonathan Donahue, went into a Burger King restaurant with the hope of robbing it, then beat the manager so severely that he sustained brain damage. After he was arrested, Donahue seemed to revel in his crime, even going so far as to have a king's crown tattooed on his back.

At the sentencing hearing, a psychiatrist provides expert testimony saying that Donahue is a diagnosed psychopath. She explains that psychopathy is a clinical diagnosis defined by impulsivity, lack of empathy, and lack of remorse. The judge tells you that the standard ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies